Relapse of duodenal ulcers was observed endoscopically after Helicobacter p
ylori eradication therapy for gastric ulcer patients in 2 of 32 successful
cases. One patient, a 40-year-old woman, received dual therapy with lansopr
azole 60mg and amoxicillin 1000mg for 2 weeks because of an intractable, ea
sily-relapsing gastric ulcer accompanied by duodenal ulcer scars that had n
ot relapsed fur 5 years. The If. pylori status was assessed by a rapid urea
se test, light microscopy, culture, and anti-Ii pylori antibody. At 24 mont
hs after the cure of if. pylori the had upper abdominal pain and showed rel
apse not of the gastric ulcer but of the duodenal ulcer. The if pylori stat
us remained negative. The other patient, a 44-year-old man, showed an activ
e gastric ulcer and duodenal ulcer scars at the first endoscopy, He receive
d the same regimen as described above. Ten weeks after completion of the er
adication therapy, endoscopy showed healing of the gastric ulcer and relaps
e of the duodenal ulcer despite successful eradication. These two cases sug
gest that Ii. pylori eradication modifies the pathophysiological condition
of gastric acid secretion and facilitates relapse of duodenal ulcers.